Immunotherapy and gene therapy combination shows promise against brain tumours
The outlook for brain tumour patients is pretty negative, with the median survival rate for patients with glioblastoma multiforme, or GBM, a mere 14.2 months.
List view / Grid view
News
Chance meeting leads to creation of antibiotic spider silk
An team of scientists at the University of Nottingham has developed a technique to produce chemically functional spider silk that can be tailored to applications used in drug delivery, regenerative medicine and wound healing.
Molecule activates pain relief and prevents high during medical marijuana use
Medicinal marijuana is used frequently as a painkiller for a variety of ailments and diseases yet its psycho active side effects are seen by many as a significant disadvantage.
TSRI’s rat study shows how brain stores memories
A new study led by scientists at the Scripps Research Institute (TSRI) sheds light on how the brain stores memories.
Scientists identify 7 proteins that make Zika so deadly
A new study by scientists at the University of Maryland School of Medicine have identified seven key proteins in the virus that may be the culprits behind its damaging effects.
Researchers develop new retinal imaging technique
Researchers at the University of Rochester Medical Centre have developed a new imaging technique to better assess eye health and potential disease.
Nanohyperthermia softens tumours to improve treatment
The mechanical resistance of tumours and collateral damage of standard treatments often hinder efforts to defeat cancers.
Mission Therapeutics appoints Colin Goddard as Chairman
Mission Therapeutics have appointed Dr Colin Goddard as non-executive Chairman, effective January 1st 2017.
Diabetic research suggests purslane herb extract mimics insulin
A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.
Can genetic testing determine antimicrobial susceptibility?
Experts at EUCAST have found that genetic methods cannot yet be used to test for susceptibility in a number of important bacterial species.
Jai Patel appointed as Chief Medical Officer of Enterome
Enterome is pleased to announce the appointments of Jai Patel, PhD as Chief Medical Officer and Roger Garceau, MD as non-executive Director.
QGel raises $12 million to grow mini-organs for drug discovery
The biomaterials company QGel has received $12 million to be used to accelerate QGel’s global expansion and broaden the company "organoids" products.
New drug could prevent graft loss in pancreatic islet transplantation
5 December 2016 | By Niamh Louise Marriott, Digital Editor
In a rodent model of islet transplantation, ARA 290 markedly reduced transplantation-induced inflammation, resulting in a marked increase in islet survival...
Enhanced CRISPR allows exploration of disease in every cell type
2 December 2016 | By Niamh Louise Marriott, Digital Editor
These systems will allow researchers worldwide to rapidly and accurately explore the changing role of genes as the cells develop into tissues...
Charles River demonstrates CRISPR/Cas9 genome engineering expertise
2 December 2016 | By Charles Rivers Laboratories
Charles River Laboratories has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology...
